GRI Bio
Logotype for GRI Bio Inc

GRI Bio (GRI) investor relations material

GRI Bio Proxy filing summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for GRI Bio Inc
Proxy filing summary28 Sep, 2026

Executive summary

  • The annual meeting will be held virtually on November 4, 2026, to enhance accessibility and reduce costs and environmental impact.

  • Stockholders as of September 22, 2026, are eligible to vote on key proposals, including director elections, auditor ratification, and equity plan amendments.

  • Proxy materials, including the 2025 annual report, are available online, and multiple voting methods are provided.

Voting matters and shareholder proposals

  • Election of W. Marc Hertz, Ph.D., and David Szekeres as Class III directors until 2029.

  • Ratification of WithumSmith + Brown, PC as independent auditor for fiscal year 2026.

  • Approval of an amendment to the 2018 Equity Incentive Plan to increase shares by 546,529 and extend the evergreen provision to January 1, 2036.

  • Approval of any adjournment of the meeting to solicit additional proxies if needed.

Board of directors and corporate governance

  • The board consists of five members, three of whom are independent, with an independent chairperson.

  • Committees include audit, compensation, and nominating/governance, all with independent members.

  • Directors are evaluated for independence and diversity in background and skills.

  • Stockholder proposals and director nominations must follow detailed procedures and deadlines.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next GRI Bio earnings date

Logotype for GRI Bio Inc
AGM 20264 Nov, 2026
GRI Bio
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next GRI Bio earnings date

Logotype for GRI Bio Inc
AGM 20264 Nov, 2026

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

GRI Bio Inc. is a biotechnology company focused on developing therapies for inflammatory, fibrotic, and autoimmune diseases. The company specializes in modulating natural killer T (NKT) cells to target immune system dysregulation. Its research and development efforts aim to advance novel small-molecule drug candidates for conditions with high unmet medical needs. The company is headquartered in La Jolla, California, and its shares are listed on the NASDAQ.